Works matching DE "INSULIN pharmacokinetics"


Results: 120
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.

    Published in:
    2011
    By:
    • Lucidi P;
    • Porcellati F;
    • Rossetti P;
    • Candeloro P;
    • Cioli P;
    • Marzotti S;
    • Andreoli AM;
    • Fede R;
    • Bolli GB;
    • Fanelli CG;
    • Lucidi, Paola;
    • Porcellati, Francesca;
    • Rossetti, Paolo;
    • Candeloro, Paola;
    • Cioli, Patrizia;
    • Marzotti, Stefania;
    • Andreoli, Anna Marinelli;
    • Fede, Raffaela;
    • Bolli, Geremia B;
    • Fanelli, Carmine G
    Publication type:
    journal article
    15

    U-500 Regular Insulin.

    Published in:
    Diabetes Care, 2010, v. 33, n. 2, p. 281, doi. 10.2337/dc09-1490
    By:
    • Davidson, Mayer B.;
    • Navar, Maria D.;
    • Echeverry, Diana;
    • Duran, Petra
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Engineering Glucose Responsiveness Into Insulin.

    Published in:
    2018
    By:
    • Kaarsholm, Niels C.;
    • Songnian Lin;
    • Lin Yan;
    • Kelly, Theresa;
    • van Heek, Margaret;
    • Mu, James;
    • Wu, Margaret;
    • Ge Dai;
    • Yan Cui;
    • Yonghua Zhu;
    • Carballo-Jane, Ester;
    • Reddy, Vijay;
    • Zafian, Peter;
    • Pei Huo;
    • Shuai Shi;
    • Antochshuk, Valentyn;
    • Ogawa, Aimie;
    • Liu, Franklin;
    • Souza, Sandra C.;
    • Wolfgang Seghezzi
    Publication type:
    journal article
    46

    Insulin: A 2014 Primer, Part 1.

    Published in:
    Primary Care Reports, 2014, v. 20, n. 8, p. 89
    By:
    • Shubrook, Jay H.;
    • Mora Becerra, Nancy;
    • Adkins, Sarah E.;
    • Guo, Aili
    Publication type:
    Article
    47
    48
    49

    Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal-Bolus Type 1): 2-year results of a randomized clinical trial

    Published in:
    Diabetic Medicine, 2013, v. 30, n. 11, p. 1293, doi. 10.1111/dme.12243
    By:
    • Bode, B. W.;
    • Buse, J. B.;
    • Fisher, M.;
    • Garg, S. K.;
    • Marre, M.;
    • Merker, L.;
    • Renard, E.;
    • Russell‐Jones, D. L.;
    • Hansen, C. T.;
    • Rana, A.;
    • Heller, S. R.
    Publication type:
    Article
    50